Atrás
Precio CYBERDYNE Inc. (CYBQF)
Gráfico del Precio de Acciones CYBQF
CYBQF Ganando
CYBERDYNE Inc.
$1.4
0%
$0
Al cierre: Jan 23, 16:00:00 GMT-5
$1.4
0%
$0
Mercado Posterior: Jan 23, 20:00:00 GMT-5
Earnings FAQ
¿Cómo se comparó el EPS reciente de CYBQF con las expectativas?
¿Cómo fue el desempeño de los ingresos de CYBERDYNE Inc. CYBQF en el último trimestre?
¿Cuál es la estimación de ingresos para CYBERDYNE Inc.?
¿Cuál es la puntuación de calidad de ganancias de CYBERDYNE Inc.?
¿Cuándo informa CYBERDYNE Inc. sus ganancias?
¿Cuáles son las ganancias esperadas de CYBERDYNE Inc.?
¿Superó CYBERDYNE Inc. las expectativas de ganancias?
Estadísticas clave
Cierre Anterior
$1.4
Precio de apertura
$1.39
Rango del día
$1.39 - $1.4
Rango de 52 semanas
$1.03 - $1.42
Volumen
100
Volumen promedio
22
EPS (TTM)
-0.01
Rendimiento de dividendos
--
Cap. de mercado
$186.8M
¿Qué es CYBERDYNE INC?
CYBERDYNE, Inc. engages in the research and development of medical welfare equipment and systems. The company is headquartered in Tsukuba-Shi, Ibaraki-Ken and currently employs 211 full-time employees. The company went IPO on 2014-03-26. The firm mainly uses human and the Internet of Things (IoH/IoT), robots, and artificial intelligence (AI) Cybernics technology to develop Cybernic systems. The company develops the Cybernics treatment service business and the training service business that utilize Cybernics technology. The firm develops in various fields centered on HAL. HAL is a robot treatment device for the purpose of improving and regenerating the physical function of patients, a welfare device and life support device for the purpose of supporting independence, and a work support equipment. The company can be used for various purposes by being worn and used by people. The firm is also involved in the productization of AI-equipped transport robots; cleaning robots; Cyin, which is used for communication with people with disabilities, and electrocardiography devices.
Características
Estrategias de Trading
© 2025 Finture Development Limited. All rights reserved